Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Enomoto, N; Ikejima, K; Yamashina, S; Enomoto, A; Nishiura, T; Nishimura, T; Brenner, DA; Schemmer, P; Bradford, BU; Rivera, CA; Zhong, Z; Thurman, RG.
Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver.
Am J Physiol Gastrointest Liver Physiol. 2000; 279(1):G100-G106 Doi: 10.1152/ajpgi.2000.279.1.G100
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Schemmer Peter
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Destruction of Kupffer cells with gadolinium chloride (GdCl(3)) and intestinal sterilization with antibiotics diminished ethanol-induced steatosis in the enteral ethanol feeding model. However, mechanisms of ethanol-induced fatty liver remain unclear. Accordingly, the role of Kupffer cells in ethanol-induced fat accumulation was studied. Rats were given ethanol (5 g/kg body wt) intragastrically, and tissue triglycerides were measured enzymatically. Kupffer cells were isolated 0-24 h after ethanol, and PGE(2) production was measured by ELISA, whereas inducible cyclooxygenase (COX-2) mRNA was detected by RT-PCR. As expected, ethanol increased liver triglycerides about threefold. This increase was blunted by antibiotics, GdCl(3), the dihydropyridine-type Ca(2+) channel blocker nimodipine, and the COX inhibitor indomethacin. Ethanol also increased PGE(2) production by Kupffer cells about threefold. This increase was also blunted significantly by antibiotics, nimodipine, and indomethacin. Furthermore, tissue triglycerides were increased about threefold by PGE(2) treatment in vivo as well as by a PGE(2) EP(2)/EP(4) receptor agonist, whereas an EP(1)/EP(3) agonist had no effect. Moreover, permeable cAMP analogs also increased triglyceride content in the liver significantly. We conclude that PGE(2) derived from Kupffer cells, which are activated by ethanol, interacts with prostanoid receptors on hepatocytes to increase cAMP, which causes triglyceride accumulation in the liver. This mechanism is one of many involved in fatty liver caused by ethanol.
Find related publications in this database (using NLM MeSH Indexing)
8-Bromo Cyclic Adenosine Monophosphate - pharmacology
Animals -
Anti-Bacterial Agents - pharmacology
Bucladesine - pharmacology
Calcium Channel Blockers - pharmacology
Cells, Cultured -
Central Nervous System Depressants - toxicity
Culture Media, Conditioned - pharmacology
Cyclic AMP - metabolism
Cyclooxygenase 2 -
Cyclooxygenase 2 Inhibitors -
Cyclooxygenase Inhibitors - pharmacology
Dinoprostone - biosynthesis
Dinoprostone - pharmacology
Ethanol - toxicity
Fatty Liver - metabolism
Fatty Liver - pathology
Female -
Gene Expression Regulation, Enzymologic -
Indomethacin - pharmacology
Isoenzymes - antagonists & inhibitors
Isoenzymes - genetics
Isoenzymes - pharmacology
Kupffer Cells - cytology
Kupffer Cells - enzymology
Lipopolysaccharides - pharmacology
Liver Cirrhosis, Alcoholic - metabolism
Liver Cirrhosis, Alcoholic - pathology
Nimodipine - pharmacology
Oligonucleotide Probes -
Organ Size -
Prostaglandin-Endoperoxide Synthases - genetics
Prostaglandin-Endoperoxide Synthases - pharmacology
RNA, Messenger - analysis
Rats -
Rats, Sprague-Dawley -
Triglycerides - metabolism

Find related publications in this database (Keywords)
fatty liver
triglyceride
adenosine 3 ',5 '-cyclic monophosphate
ethanol
© Med Uni GrazImprint